• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines

    2010-07-07 00:59:38ChaoWenXiaoXinBoXueHuiZhangWeiGaoYuanYuKunChenJianWeiZhengandCongJunWang

    Chao-Wen Xiao, Xin-Bo Xue, Hui Zhang, Wei Gao, Yuan Yu, Kun Chen, Jian-Wei Zheng and Cong-Jun Wang

    Shanghai, China

    Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines

    Chao-Wen Xiao, Xin-Bo Xue, Hui Zhang, Wei Gao, Yuan Yu, Kun Chen, Jian-Wei Zheng and Cong-Jun Wang

    Shanghai, China

    BACKGROUND:Melanoma differentiation-associated gene-7 (MDA-7)/interleukin-24 (IL-24) is a novel tumor suppressor gene, which has suppressor activity in a broad spectrum of human cancer cells. We investigated the effect of the replication-competent oncolytic adenovirus SG600-IL24 and replication-incompetent adenovirus Ad.IL-24, both expressing human MDA-7/IL-24 on the hepatocellular carcinoma cell lines HepG2, Hep3B, SMMC-7721, HCCLM3, and the normal liver cell line L02.

    METHODS:Hepatocellular carcinoma cell lines and the normal liver cell line were infected with SG600-IL24 and Ad.IL-24. The mRNA and protein expression of MDA-7/IL-24 in infected cells was confirmed by RT-PCR, ELISA, and Western blotting. MTT assay was used to investigate the proliferation effect. Hoechst staining and Annexin-V and PI staining were performed to study the MDA-7/IL-24 gene expressed in HCC cell lines and the normal liver cell line. Flow cytometry was used to analyse the cell cycle.

    RESULTS:RT-PCR, ELISA and Western blotting confirmed that the exogenous MDA-7/IL-24 gene was highly expressed in cells infected with SG600-IL24. MTT and apoptosis detection indicated that SG600-IL24 induced growth suppression, promoted apoptosis, and blocked cancer cell lines in the G2/M phase in hepatocellular carcinoma cell lines but not in the normal liver cell line.

    CONCLUSIONS:SG600-IL24 selectively induces growth suppression and apoptosis in hepatocellular carcinomacell linesin vitrobut not in the normal liver cell line L02. Compared with Ad.IL-24, SG600-IL24 dramatically enhances antitumor activity in hepatocellular carcinoma cell lines.

    (Hepatobiliary Pancreat Dis Int 2010; 9: 615-621)

    melanoma differentiation-associated gene-7; interleukin-24; oncolytic adenovirus; hepatocellular carcinoma; gene therapy

    Introduction

    Melanoma differentiation-associated gene-7 (MDA-7), renamed interleukin-24 (IL-24), was identified by Fisher in 1995 through combination of recombinant fibroblast interferon-β and protein kinase C activator mezerein subtraction hybridization.[1]MDA-7/IL-24 can induce growth inhibition and apoptosis in melanoma and other types of cancer cell.[2-5]It was hailed as a novel and interesting development in experimental tumor therapy in the early 21st century.[6]Our previous studies show that Ad.IL-24 selectively destroys a variety of liver cancer cells without any toxic effects and growth inhibition of the normal liver cell line L02. Ad.IL-24 facilitates the release of CytC and Smac from the mitochondria to the cytoplasm, independent of the Fas pathway.[7]MDA-7/IL-24 also inhibits the growth and metastasis of high-transfer (HCCM6) liver xenograft tumors, with synergistic effect when combined with doxorubicin. However, the replication-defective adenovirus has poor targeting, low transfection efficiency, low gene expression effect, and severe immune reaction, therefore limiting its further application to cancer gene therapy. The oncolytic adenovirus, a non-defective virus, has been found to be capable of higher transfection efficiency because the exogenous gene can selectively replicate in tumor cellsand lyse them, with almost no effect on normal cells.[8]Therefore, we used this strategy to construct replicationcompetent oncolytic adenovirus SG600-IL24 which carries human MDA-7/IL-24. Four kinds of liver cancer cell lines and the normal liver cell line were infected to assess gene expression, cell growth inhibition, and cytotoxicity in different cells.

    Methods

    Cell lines and culture conditions

    The HCC cell lines HepG2, Hep3B, SMMC-7721, and HCCLM3 and the normal human liver cell line L02 were from the Institute of Liver Cancer of Fudan University. The cell lines were cultured in high glucose DMEM (HyClone, USA) supplemented with 10% FBS (Gibco, USA). SMMC-7721 and L02 were cultured in RPMI-1640 (HyClone, USA) supplemented with 10% FBS. All cell lines were cultured at 37 ℃ in a 5% CO2 humidified incubator.

    Virus construction and production

    Ad.IL-24 was constructed as in our previous work.[9]The oncolytic adenoviruses SG600-IL24 and SG600-EGFP were constructed and amplified as previously described. The IL-24 expression cassette was released from pZD55-IL-24 and introduced into pClon9-INS to produce pClon9-INS-IL24. Using a plasmid transfection method, we co-transfected the pSG600-IL24 and adenovirus skeletal plasmid pPE3 into HEK293 cells to construct the recombinant adenovirus vector SG600-IL24, which carried the mda-7 gene, by intracellular homologous recombination. The genomes were analyzed to confirm the recombinant structure and then the virus was plaque purified and amplified in HEK293 cells. The virus titers were determined by TCID50 assay in HEK293 cells. The titer of SG600-IL24 was 2.25× 1010PFU/ml, SG600-EGFP was 2.79×1010PFU/ml, and Ad.IL-24 was 7.1×109PFU/ml; they were stored at -80 ℃.

    Reagents

    RT-PCR kit (Takara, Japan), enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN, USA), MTT (Sigma, St. Louis, MO, USA), Hoechst33258 reagent (Sigma), Annexin-V/PI kit (Sigma), and anti-MDA-7/IL-24 (Abcam, UK).

    Virus infection

    Six-well plates for each cell line were divided into 4 groups: control, Ad.IL-24, SG600-EGFP and SG600-IL24; the control group was treated with serum-free DMEM. The oncolytic adenovirus infected the cells at a MOI (multiplicity of infection, MOI) of 10.

    Expression of MDA-7/IL-24 determined by RT-PCR

    Cells were harvested 24 hours after SG600-IL24 infection to determine mRNA expression of MDA-7/ IL-24. Total RNA was extracted and RT-PCR was performed as previously described. The sequences of primers of MDA-7 mRNA were: sense, 5'-GGG CTG TGA AAG ACA CTA T-3', antisense, 5'-GCA TCC AGG TCA GAA GAA-3'. The length of amplified fragment was 381bp. The sequences of primers of β-actin were: sense, 5'-CCT TCC TGG GCA ATG GAG TCC T-3', and antisense, 5'-GGA ACA ATG ATC TTG ATC TT-3'. The length of amplified fragment was 201bp. Reaction mixtures with corresponding primers were amplified under the following conditions: denaturation at 94 ℃ 5 minutes; denaturation at 94 ℃ 30 seconds, annealing at 56 ℃ 30 seconds, and extension at 72 ℃ 45 seconds for 30 cycles; then extension at 72 ℃ 10 minutes to ensure full extension of the product. The amplified products were visualized by electrophoresis on a 1% agarose gel.

    Detection of IL-24 by ELISA

    Two-antibody sandwich ELISA was developed for detection of human MDA-7/IL-24. The antibodies used were monoclonal mouse anti-human IL-24 (R&D Systems), and peroxidaseconjugated rabbit anti-goat IgG (R&D Systems). The cell culture supernatant was collected at 24 hours, 48 hours and 72 hours and stored at -20 ℃. The concentrations of MDA-7/IL-24 in the supernatant at different times were evaluated by ELISA. The absorbance was read at 450 nm. The concentration of IL-24 was evaluated with a standard curve.

    MTT assay to determine cell growth

    The cells were seeded into 96-well tissue culture plates (1×103cells per well), and treated with PBS, 10 MOI of Ad.IL-24, SG600-EGFP, or SG600-IL24 the next day. After cultivation for 24 hours, the medium was removed, and fresh medium containing 0.5 mg/ml MTT was added to each well. The cells were incubated at 37 ℃for 4 hours, and then the supernatant was removed, and about 150 μl dimethylsulfoxide was added to each well and cells incubated for another 10 minutes at 37 ℃with gentle shaking. Absorbance was read on a Bio-Rad microplate reader at 595 nm.

    Western blotting analysis

    Cell lines were cultured in 6-well plates, and cells receiving different treatments were collected at theindicated times. Forty-eight hours later the cells were collected and suspended in lysis BCA method for protein quantitation. A total of 25 μg of proteins was applied to 15% SDS-PAGE and transferred to polyvinylidene fluoride membranes. The membranes were probed with polyclonal antibodies to MDA-7/IL-24 and β-actin, then the corresponding fluorescent secondary antibody hybridization, and finally the second antipolyvinylidene fluoride membrane fluorescence signal was detected with infrared imaging systems.

    Hoechst33258 staining

    Forty-eight hours after infection, cells were washed twice with PBS and fixed in 1 ml of 4% paraformaldehyde for 10 minutes at 4 ℃. After two washes with PBS, each well was stained with 100 μl Hoechst33258 in PBS for 15 minutes in the dark at room temperature, and then 1000 cells were counted under a fluorescence microscope. Nuclear fragmentation was visualized using a fluorescence microscope (TE2000-U, Nikon, JPN). Apoptotic cells were identified by condensation and fragmentation of nuclear chromatin.

    Fluorescence-activated cell sorter (FACS) analysis

    Cells were harvested 48 hours after administration, trypsinized and washed twice with complete media 48 hours later. Aliquots of cells (1×106) were resuspended in 500 μl binding buffer and stained with 5 μl fluorescein isothiocyanate (FITC)-labeled annexin-V according to the manufacturer's instructions. Propidium iodide (PI, 5 μl) was added to the samples after staining with annexin-V, and then put in the dark for 30 minutes. Flow cytometry (BD, FACSCalibur, USA) was performed immediately after staining.

    Cell-cycle analysis

    Cells were cultured as previously, and after reaching 30% confluence they were treated with DMEM without fetal bovine serum (FBS) for 24 hours for synchronization. The cells were divided into 4 groups: DMEM, Ad.IL-24, SG600-EGFP, and SG600-IL24. Forthy-eight hours later, the cells were harvested using trypsin and the cell concentration adjusted to l×106/ml. After the cells were fixed in 70% cold ethanol overnight at -20 ℃, they were washed with phosphate buffered saline (PBS), and aliquots of 1×106cells were resuspended in 1 ml PBS containing 1 mg/ml of RNase A and 0.5 mg/ml PI. After 30 minutes of incubation, the cells were analyzed by flow cytometry using a FACScan flow cytometer (BD, FACSCalibur, USA). The treated cells were evaluated by FACS analysis for identifying the cells at different stages of the cell cycle. The percentages of G0/G1, S, and G2/M stage cells were determined using multicycle software and the results analyzed using analysis of variance.

    Statistical analysis

    All analyses were performed with SPSS14.0 software. All the experiments were performed at least for three times. Results are expressed as mean±SD. Statistical comparisons were made using analysis of variance. APvalue less than 0.05 was considered statistically significant.

    Results

    SG600-IL24 mediated ectopic MDA-7/IL-24 expression in cells

    The expression of MDA-7/IL-24 mRNA was markedly upregulated in the normal liver cell line (L02) as well as in the different metastatic potential HCC cell lines (HepG2, Hep3B, SMMC-7721, and HCCLM3) that were infected with SG600-IL24. In contrast, cells infected with Ad.IL-24, SG600-EGFP, and DMEM expressed very low levels of MDA-7/IL-24 (Fig. 1).

    Detection of MDA-7/IL-24 in supernatants by ELISA

    Fig. 1. Expression of MDA-7/IL-24 mRNA in a variety of HCC cell lines and normal liver cell line. A: Lanes 1-4, Ad.IL-24, SG600-EGFP, control, and SG600-IL24 groups, respectively. B: corresponding β-actin.

    Fig. 2. Protein expression of MDA-7/IL-24 after SG600-IL24 transfection into HCC cell lines and normal liver cell line. Lanes 1 and 6, control; lane 2, Ad.IL-24 group; lane 7, SG600-EGFP group; lanes 3-5, HepG2, Hep3B, and SMMC-7721 SG600-IL24 groups, respectively; lanes 8 and 9, HCCLM3 and L02 SG600-IL24 groups, respectively.

    Fig. 3. Cell viability of different HCC cell lines and normal liver cell line infected with the oncolytic adenovirus SG600-IL24 and replication-incompetent adenovirus Ad.IL-24 measured by MTT assay at 24, 48, 72 and 96 hours postinfection. Results are presented as mean±SD (n=5) and are expressed as a percentage relative to the DMEM-treated control cells. Data are presented as mean±SD of three independent experiments.

    Table 1. Protein concentrations of MDA-7/IL-24 in different HCC cell lines and normal cell line (pg/ml)

    Table 2. Analysis of apoptosis by Hoechst staining

    In SG600-IL24-treated cells, the concentrations of MDA-7/IL-24 protein in supernatants increased in a time-dependent manner. Endogenous MDA-7/IL-24 expression was not detected in cells treated with SG600-EGFP and control groups (Table 1).

    Protein expression of MDA-7/IL-24 by Western blotting

    Five cells in the control, Ad.IL-24 and SG600-EGFP groups had no MDA-7/IL-24 protein expression, but transfection of the oncolytic adenovirus SG600-IL24 showed very high expression of MDA-7/IL-24 48 hours later (Fig. 2).

    Growth suppression and viability assays

    To investigate whether SG600-IL24 inhibits cell proliferation, HCC cells HepG2, Hep3B, SMMC-7721, HCCLM3 and the normal liver cell line L02 were infected with SG600-IL24, and proliferation and cell viability were determined by MTT. There was no proliferation arrest effect in normal liver cell line L02, regardless of treatment with DMEM, Ad.IL-24 or SG600-EGFP. However, the anti-proliferative activity of SG600-IL24 was readily apparent in HCC cell lines HepG2, Hep3B, SMMC-7721, and HCCLM3; the inhibition ratios were 75±2.5%, 85±2.0%, 86±3.5%, and 72±1.8%, respectively (Fig. 3).

    SG600-IL24 induced apoptosis in HCC cell lines as assessed by Hoechst staining

    Hoechst staining showed that SG600-IL24 induced apoptosis in human HCC cells lines HepG2, Hep3B, SMMC-7721, and HCCLM3 (Table 2). SG600-IL24-mediated apoptosis in HCC cell lines was higher than in the other groups (HepG2:F=156.6,P<0.05; Hep3B:F=202.4,P<0.05; SMMC-7721:F=122.5,P<0.05;HCCLM3:F=138.0,P<0.05). These data indicated that SG600-IL24 induced apoptosis in HCC cell lines. In contrast, there were no apparent changes in the normal liver cell line L02, where the rates of apoptosis were 1.0%, 1.4%, 1.2% and 2.0%, respectively (F=1.78,P>0.05).

    Table 3. Analysis of apoptosis in HCC cell lines by flow cytometry

    Fig. 4. SG600-IL24 induces G2/M arrest in HCC cell lines.

    Apoptosis affected assay by flow cytometry

    Annexin-V and PI staining assays with flow cytometry quantified the effect of SG600-IL24 on apoptosis induction in the HCC cell lines HepG2, Hep3B, SMMC-7721, HCCLM3 and the normal liver cell line L02. The percentage of apoptosis in HCC cell lines increased significantly in the SG600-IL24-infected compared to the control, SG600-EGFP, and Ad.IL-24 infected cells (HepG2:F=203.4,P<0.05; Hep3B:F=313.2,P<0.05; SMMC-7721:F=130.5,P<0.05; HCCLM3:F=142.3,P<0.05) (Table 3). When compared L02 with HCC cell lines, the apoptosis rate was only increased by 0.75%, demonstrating that SG600-IL24 infection can kill HCC cell lines but not normal liver cell line.

    Cell cycle analysis by flow cytometry

    Cell cycle phases assayed with flow cytometry showed that SG600-IL24 induced a G2/M accumulation in HepG2, Hep3B, SMMC-7721, and HCCLM3 carcinoma cell lines compared with the control, Ad.IL-24 and SG600-EGFP groups (P<0.05; Fig. 4). The rates of G2/M phase were 35.4±4.2%, 47.3±6.2%, 40.5± 5.0%, and 45.5±4.0% respectively. However, the rates of G2/M phase in the L02 cell line were 5.5±0.3%, 5.6± 0.2%, 6.3±0.4%, and 6.8±0.7%, respectively (P>0.05). These results showed that SG600-IL24 infection induced an increase in the G2/M proportion of the cell cycle in HCC cell lines but not in normal liver cell lines.

    Discussion

    Hepatocellular carcinoma (HCC) is one of the highest malignant tumors. The annual morbidity and mortality associated with HCC are the second highest among tumors.[10]In addition, HCC is characterized by poor prognosis. To address this, cancer gene therapy has been on the rise. Recently, sorafenib has been approved for clinical application.[11]However, its actual effects are still being examined. Genes or drugs that can treat tumor cells whetherin vivoor specific to metastatic tumor cells, without any toxic effects to normal cells, are essential to the treatment of liver cancer and other tumors.

    MDA-7/IL-24, IL-24, is a new member of the IL-10, class-II family of cytokines. Studies have found that MDA-7/IL-24 not only induces growth inhibition of melanoma cells but also facilitates growth suppression and apoptosis in a broad range of carcinoma cell lines, such as those of ovarian cancer,[12,13]and carcinomas of the lungs,[14,15]breast,[16]pancreas,[17]glioma,[17,18]prostate[19]and colon[20]among others. Studies have likewise indicated that increased expression of the IL-24 gene suppresses growth and induces apoptosis in a variety of cancer cells with single or multiple genetic defects, including alterations in p53, p16/INK4a, and Rb.[21,22]

    Gene therapy for liver cancer is a current research focus; most of the reported methods are not tumorspecific but affect normal cells, which limits their clinical application. Gene therapy that is capable of selectively curing tumor cells without affecting normal cells can be explored.[23]In this study, an oncolytic adenovirus, with the characteristics of antitumor activity and proliferation and replication in tumor cells specifically, was used as a carrier. These oncolytic adenoviruses can make the exogenous gene copy thousands of times and enhance the effect of the anticancer gene in a similar manner, ultimately killing tumor cells for therapeutic purposes.[24]Tumor-specific oncolytic adenovirus vectors have the capability to cure specific infections of tumor cells, amplify in a large number of infected cells, and dissolve tumor cells. Therefore they are promising gene therapy vectors with anti-tumor effects.[25]In this study we constructed adenovirus SG600-IL24, which has E1B 55 kDa defective oncolytic adenovirus (ZD55). It replicates in tumor cells and causes a significant cytotoxic effect, whilenormal cells show little or no toxicity.[26]SG600-IL24 was constructed by oncolytic adenovirus SG600 vector which has the telomerase reverse transcriptase promoter (TERTp), and hypoxia regulatory element (HRE) controls the adenovirus proliferation genes E1a and E1b. It deletes the E1a gene, which promotes virus-specific replication in tumor cells, therefore it has enhanced effectiveness and safety for gene therapy.[27]

    In contrast to the replication-incompetent adenovirus Ad.IL-24, the oncolytic adenovirus can replicate in and lyse tumor cells exclusively, inducing a high expression of MDA-7/IL-24 in these cells. This high expression of MDA-7/IL-24 can selectively kill cancer cells simultaneously. Moreover, when the oncolytic adenovirus selectively kills tumor cells, MDA-7/IL-24 can be released to the blood, indicating a potent "bystander" antitumor activity.[28]It can also kill distant micrometastatic lesions resulting from radical treatment.

    SG600-IL24 was utilized as a vector. RT-PCR, ELISA, and Western blotting demonstrated that MDA-7/IL-24 was successfully transfected into the HCC cell lines and normal liver cell line. The control group and the SG600-EGFP group did not express the MDA-7/IL-24 gene and protein. Although the SG600-IL24 group comprising five kinds of cell lines expressed the MDA-7/ IL-24 protein, the effects were different. ELISA results showed that the expression of secreted and intracellular MDA-7/IL-24 proteins increased in a time-dependent manner in the SG600-IL24 group. This indicates that the enhanced killing was due to increased MDA-7/ IL-24 protein expression. At the same time, the rate of apoptosis increased with time. These findings suggest that there is a positive correlation between time and the protein concentration after SG600-IL24 was infected into the HCC cell lines. Flow cytometry results showed that SG600-IL24 significantly inhibited the growth of tumor cells, promoted the apoptosis of tumor cells, and blocked tumor cells in the G2/M phase. Normal L02 liver cells were not affected although an increase in G2/M phase by 1.3% was observed. Annexin-V and PI staining by flow cytometry showed that the early and late apoptosis rates in HepG2, Hep3B, SMMC-7721, and HCCLM3 were 56.59%, 78.36%, 34.46%, and 40.03%. The apoptosis rate was only 0.75% in the normal liver cell line L02. These results demonstrated that SG600-IL24 did not promote apoptosis in the normal liver cell line. MTT and Hoechst33258 staining results suggested that SG600-IL24 promoted apoptosis and induced the killing effect in a variety of different HCC cell lines with metastatic potential but not in the normal liver cell line L02. These effects showed stronger antitumor activity than the replication-incompetent adenovirus Ad.IL-24, which showed little or low killing capacity under the same conditions.

    The HCC cell line HepG2 is a wild type in the gene p53 and a mutant type in the gene Rb. Hep3B is a line with the p53 gene deleted. HCCLM3 is a mutant type in the gene p53.[29-32]Although these lines have different gene types, they induce apoptosis and growth arrest by infection with SG600-IL24. The results demonstrated that SG600-IL24 killed several kinds of tumor cells independent of the state of p53. Hep3B is a line without metastatic potential. In comparison, HCCLM3 and SMMC-7721 are lines with high metastatic potential. Research has shown that HCCLM3 is a strong metastatic line which can develop liver cancer metastasis in 100% of nude mice.[29-32]Therefore, SG600-IL24 can facilitate HCC cell lines with different metastatic potential.

    In conclusion, SG600-IL24 can induce growth suppression, promote apoptosis, and block cancer cell lines in the G2/M phase in HCC cell lines without any toxic effect on normal liver cell line lines. In contrast with Ad.IL-24, SG600-IL24 enhances antitumor activity in HCC cell lines dramatically. These findings provide support for future clinical applications of MDA-7/IL-24 in the gene therapy of HCC. Therefore, the strategy called targeted gene-virotherapy is an efficient approach in anticancer therapies.

    Acknowledgements

    We thank Virginia Commonwealth University Professor Paul B. Fisher for his instruction and encouragement. We are also grateful to Qi-Jun Qian of Shanghai Eastern Hepatobiliary Surgery Hospital for his guidance on virus construction and laboratory techniques.

    Funding:This work was supported by a grant from the National Natural Science Foundation of China (30872510).

    Ethical approval:Not needed.

    Contributors:WCJ and ZH proposed the study. XCW wrote the first draft. CK analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. WCJ is the guarantor.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004;22:929-979.

    2 Yacoub A, Hamed HA, Allegood J, Mitchell C, Spiegel S, Lesniak MS, et al. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells. Cancer Res 2010;70:1120-1129.

    3 Park MA, Walker T, Martin AP, Allegood J, Vozhilla N, Emdad L, et al. MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism. Mol Cancer Ther 2009;8:1280-1291.

    4 Hamed HA, Yacoub A, Park MA, Eulitt P, Sarkar D, Dimitriev IP, et al. OSU-03012 enhances Ad.mda-7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins. Cancer Biol Ther 2010;9.

    5 Maarof G, Bouchet-Delbos L, Gary-Gouy H, Durand-Gasselin I, Krzysiek R, Dalloul A. Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells. Blood 2010;115:1718-1726.

    6 Los M. New, exciting developments in experimental therapies in the early 21st century. Eur J Pharmacol 2009;625:1-5.

    7 Wang C, Xue X, Yi J, Wu Z, Chen K, Zheng J, et al. Replicationincompetent adenovirus vector-mediated MDA-7/IL-24 selectively induces growth suppression and apoptosis of hepatoma cell Line SMMC-7721. J Huazhong Univ Sci Technolog Med Sci 2008;28:80-83.

    8 Wei N, Fan JK, Gu JF, Liu XY. Double-regulated oncolytic adenovirus-mediated interleukin-24 overexpression exhibits potent antitumor activity on gastric adenocarcinoma. Hum Gene Ther 2010;21:855-864.

    9 Wang CJ, Xue XB, Yi JL, Chen K, Zheng JW, Wang J, et al. Melanoma differentiation-associated gene-7, MDA-7/IL-24, selectively induces growth suppression, apoptosis in human hepatocellular carcinoma cell line HepG2 by replicationincompetent adenovirus vector. World J Gastroenterol 2006; 12:1774-1779.

    10 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.

    11 Furuse J. Growth factors as therapeutic targets in HCC. Crit Rev Oncol Hematol 2008;67:8-15.

    12 Mahasreshti PJ, Kataram M, Wu H, Yalavarthy LP, Carey D, Fisher PB, et al. Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy. Gynecol Oncol 2006;100:521-532.

    13 Gopalan B, Litvak A, Sharma S, Mhashilkar AM, Chada S, Ramesh R. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Cancer Res 2005;65:3017-3024.

    14 Kawabe S, Nishikawa T, Munshi A, Roth JA, Chada S, Meyn RE. Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol Ther 2002;6:637-644.

    15 Ramesh R, Ito I, Gopalan B, Saito Y, Mhashilkar AM, Chada S. Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells. Mol Ther 2004;9:510-518.

    16 McKenzie T, Liu Y, Fanale M, Swisher SG, Chada S, Hunt KK. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery 2004;136:437-442.

    17 Lebedeva IV, Su ZZ, Sarkar D, Gopalkrishnan RV, Waxman S, Yacoub A, et al. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis. Oncogene 2005; 24:585-596.

    18 Yacoub A, Mitchell C, Hong Y, Gopalkrishnan RV, Su ZZ, Gupta P, et al. MDA-7 regulates cell growth and radiosensitivityin vitroof primary (non-established) human glioma cells. Cancer Biol Ther 2004;3:739-751.

    19 Lebedeva IV, Su ZZ, Sarkar D, Kitada S, Dent P, Waxman S, et al. Melanoma differentiation associated gene-7, mda-7/ interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. Cancer Res 2003;63:8138-8144.

    20 Zhao L, Gu J, Dong A, Zhang Y, Zhong L, He L, et al. Potent antitumor activity of oncolytic adenovirus expressing mda-7/ IL-24 for colorectal cancer. Hum Gene Ther 2005;16:845-858.

    21 Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, Fisher PB. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 2002;21:708-718.

    22 Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 2001;20:7051-7063.

    23 Su ZZ, Lebedeva IV, Sarkar D, Gopalkrishnan RV, Sauane M, Sigmon C, et al. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 2003;22:1164-1180.

    24 Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY, et al. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res 2003;13:481-489.

    25 Crompton AM, Kirn DH. From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development. Curr Cancer Drug Targets 2007;7:133-139.

    26 Liu XY, Gu JF. Targeting gene-virotherapy of cancer. Cell Res 2006;16:740.

    27 Luo J, Xia Q, Zhang R, Lv C, Zhang W, Wang Y, et al. Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene. Clin Cancer Res 2008;14:2450-2457.

    28 Sarkar D, Su ZZ, Park ES, Vozhilla N, Dent P, Curiel DT, et al. A cancer terminator virus eradicates both primary and distant human melanomas. Cancer Gene Ther 2008;15:293-302.

    29 Yang J, Qin LX, Li Y, Ye SL, Liu YK, Gao DM, et al. Molecular cytogenetic characteristics of the human hepatocellular carcinoma cell line HCCLM3 with high metastatic potential: comparative genomic hybridization and multiplex fluorescence in situ hybridization. Cancer Genet Cytogenet 2005;158:180-183.

    30 Tian B, Li Y, Ji XN, Chen J, Xue Q, Ye SL, et al. Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential. J Cancer Res Clin Oncol 2005;131:80-86.

    31 Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY, et al. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 2004;4:982-994.

    32 Wu X, Jia HL, Wang YF, Ren N, Ye QH, Sun HC, et al. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma. Oncogene 2006;25:1832-1840.

    May 24, 2010

    Accepted after revision August 12, 2010

    Author Affiliations: Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China (Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW); Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China (Zhang H, Gao W and Wang CJ)

    Cong-Jun Wang, MD, PhD, Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China (Tel: 86-21-38804518ext2704; Email: wcj902@163.com)

    ? 2010, Hepatobiliary Pancreat Dis Int. All rights reserved.

    久久香蕉激情| 老鸭窝网址在线观看| 欧美久久黑人一区二区| aaaaa片日本免费| 久久香蕉激情| 99香蕉大伊视频| 大香蕉久久成人网| 国产成人精品无人区| 视频区欧美日本亚洲| 99精品欧美一区二区三区四区| 免费少妇av软件| 日韩中文字幕欧美一区二区| 高清欧美精品videossex| 日韩免费高清中文字幕av| 青青草视频在线视频观看| 十分钟在线观看高清视频www| 欧美人与性动交α欧美精品济南到| 国产黄色免费在线视频| 黄频高清免费视频| 亚洲精品国产精品久久久不卡| 久久久精品免费免费高清| 日本av免费视频播放| 免费在线观看完整版高清| 搡老岳熟女国产| 亚洲国产成人一精品久久久| 国产精品国产高清国产av | 热99久久久久精品小说推荐| 国产无遮挡羞羞视频在线观看| 日韩欧美国产一区二区入口| 国产真人三级小视频在线观看| 99re6热这里在线精品视频| 黄色视频不卡| 国产精品香港三级国产av潘金莲| 亚洲熟女毛片儿| 美女国产高潮福利片在线看| 大片免费播放器 马上看| 成人18禁在线播放| 一级毛片电影观看| 一级毛片精品| 精品久久蜜臀av无| 高清黄色对白视频在线免费看| 成人免费观看视频高清| 国产精品九九99| 国产欧美日韩精品亚洲av| 亚洲成人国产一区在线观看| 久热这里只有精品99| 亚洲国产看品久久| 精品亚洲成国产av| 伊人久久大香线蕉亚洲五| 日韩制服丝袜自拍偷拍| 少妇 在线观看| 欧美激情久久久久久爽电影 | 高清黄色对白视频在线免费看| 午夜福利免费观看在线| 午夜福利在线免费观看网站| 51午夜福利影视在线观看| 满18在线观看网站| 母亲3免费完整高清在线观看| 色精品久久人妻99蜜桃| 亚洲国产精品一区二区三区在线| 亚洲精品中文字幕一二三四区 | 成人18禁高潮啪啪吃奶动态图| 搡老乐熟女国产| 国产精品一区二区免费欧美| 精品第一国产精品| 最近最新中文字幕大全电影3 | 亚洲精品国产色婷婷电影| www.熟女人妻精品国产| 成人影院久久| 我的亚洲天堂| 国产成人av激情在线播放| 青青草视频在线视频观看| 国精品久久久久久国模美| 亚洲精品av麻豆狂野| 欧美人与性动交α欧美软件| 黑人操中国人逼视频| 色播在线永久视频| 久久精品亚洲熟妇少妇任你| 国产精品1区2区在线观看. | av国产精品久久久久影院| 亚洲中文日韩欧美视频| 一本久久精品| 老熟妇乱子伦视频在线观看| 另类精品久久| 精品亚洲乱码少妇综合久久| 成年动漫av网址| h视频一区二区三区| 精品人妻熟女毛片av久久网站| 欧美黑人欧美精品刺激| 一二三四社区在线视频社区8| 欧美日韩亚洲综合一区二区三区_| 国产成人精品久久二区二区91| 午夜福利在线观看吧| 久久精品亚洲av国产电影网| 亚洲伊人久久精品综合| 性少妇av在线| 国产精品欧美亚洲77777| 国产在线精品亚洲第一网站| 亚洲欧美日韩高清在线视频 | 他把我摸到了高潮在线观看 | 亚洲av电影在线进入| 国产精品国产av在线观看| 脱女人内裤的视频| 黑人操中国人逼视频| 黄色片一级片一级黄色片| 国产精品美女特级片免费视频播放器 | 国产精品一区二区在线观看99| 久久天堂一区二区三区四区| 国产又色又爽无遮挡免费看| 国产一卡二卡三卡精品| 精品久久久久久久毛片微露脸| 欧美精品人与动牲交sv欧美| 香蕉国产在线看| 首页视频小说图片口味搜索| 日日夜夜操网爽| 午夜福利影视在线免费观看| 欧美乱码精品一区二区三区| 欧美精品亚洲一区二区| 久久国产精品影院| 午夜精品国产一区二区电影| 久久精品aⅴ一区二区三区四区| avwww免费| 久久久欧美国产精品| 美女高潮喷水抽搐中文字幕| 欧美日韩中文字幕国产精品一区二区三区 | 老司机深夜福利视频在线观看| 免费日韩欧美在线观看| 女同久久另类99精品国产91| 丰满饥渴人妻一区二区三| 精品人妻1区二区| 美女午夜性视频免费| 欧美老熟妇乱子伦牲交| 91精品三级在线观看| 亚洲性夜色夜夜综合| 国产精品久久久久久人妻精品电影 | 欧美日韩亚洲国产一区二区在线观看 | 久久精品国产a三级三级三级| 少妇被粗大的猛进出69影院| 色94色欧美一区二区| 这个男人来自地球电影免费观看| 18禁黄网站禁片午夜丰满| 久久久久国产一级毛片高清牌| 国产一区二区 视频在线| 国产99久久九九免费精品| 女性被躁到高潮视频| 精品国产国语对白av| 午夜激情av网站| 人人妻,人人澡人人爽秒播| 久热这里只有精品99| 国产免费现黄频在线看| cao死你这个sao货| 国产一区二区在线观看av| 国产人伦9x9x在线观看| 精品少妇内射三级| 亚洲欧美激情在线| 国产精品影院久久| 国产在线视频一区二区| 亚洲性夜色夜夜综合| 久9热在线精品视频| 欧美一级毛片孕妇| 精品卡一卡二卡四卡免费| 建设人人有责人人尽责人人享有的| 美女视频免费永久观看网站| 国产在线观看jvid| 黄色视频不卡| 中国美女看黄片| 国产成人欧美在线观看 | 黑人猛操日本美女一级片| 美女福利国产在线| 一级a爱视频在线免费观看| 黄色 视频免费看| 久久狼人影院| 免费观看人在逋| 一边摸一边抽搐一进一小说 | 日韩大片免费观看网站| 国产一区二区 视频在线| 一本综合久久免费| 国产亚洲av高清不卡| 十八禁高潮呻吟视频| 精品视频人人做人人爽| 成人国产av品久久久| 久久精品亚洲精品国产色婷小说| 黄网站色视频无遮挡免费观看| 免费少妇av软件| 19禁男女啪啪无遮挡网站| 这个男人来自地球电影免费观看| 亚洲第一欧美日韩一区二区三区 | 亚洲专区国产一区二区| 涩涩av久久男人的天堂| 80岁老熟妇乱子伦牲交| 99精品欧美一区二区三区四区| 满18在线观看网站| 首页视频小说图片口味搜索| 国产99久久九九免费精品| 欧美日韩av久久| 在线观看人妻少妇| 一本一本久久a久久精品综合妖精| 国产免费福利视频在线观看| 精品熟女少妇八av免费久了| 法律面前人人平等表现在哪些方面| 亚洲av片天天在线观看| 国产日韩欧美视频二区| 在线观看一区二区三区激情| 99re6热这里在线精品视频| 99国产精品一区二区蜜桃av | 青草久久国产| 91麻豆av在线| 欧美日韩国产mv在线观看视频| 久热爱精品视频在线9| 国产视频一区二区在线看| 亚洲专区中文字幕在线| 久久久欧美国产精品| 欧美精品一区二区大全| 日本wwww免费看| 精品少妇久久久久久888优播| 午夜激情av网站| 国产xxxxx性猛交| 欧美黑人欧美精品刺激| 久久久久久久久久久久大奶| 国产av又大| 欧美中文综合在线视频| 天天躁日日躁夜夜躁夜夜| 精品亚洲成国产av| 人妻一区二区av| 高清黄色对白视频在线免费看| 国产成人一区二区三区免费视频网站| 人人妻人人添人人爽欧美一区卜| 我要看黄色一级片免费的| 亚洲专区中文字幕在线| 国产欧美日韩精品亚洲av| 国产精品偷伦视频观看了| 亚洲avbb在线观看| 久久精品亚洲精品国产色婷小说| 成人国产一区最新在线观看| 国产精品免费一区二区三区在线 | 国产在线一区二区三区精| 黄片小视频在线播放| 免费女性裸体啪啪无遮挡网站| 三级毛片av免费| 丝袜美足系列| 亚洲国产欧美日韩在线播放| 男女床上黄色一级片免费看| 亚洲人成电影观看| 男女高潮啪啪啪动态图| 久久久久久免费高清国产稀缺| 午夜福利一区二区在线看| 国产av精品麻豆| 国产色视频综合| 亚洲精品国产色婷婷电影| 香蕉久久夜色| 十八禁高潮呻吟视频| 国产成人精品在线电影| 久9热在线精品视频| 久久99热这里只频精品6学生| 午夜两性在线视频| 久久国产精品男人的天堂亚洲| 视频区欧美日本亚洲| 人人妻人人澡人人看| 久久99热这里只频精品6学生| 亚洲精品国产区一区二| 国产免费av片在线观看野外av| 老鸭窝网址在线观看| 2018国产大陆天天弄谢| 国产1区2区3区精品| 丝袜在线中文字幕| 18禁国产床啪视频网站| 1024视频免费在线观看| 亚洲avbb在线观看| 岛国在线观看网站| 国产不卡一卡二| 1024视频免费在线观看| 欧美中文综合在线视频| 亚洲三区欧美一区| 黄片小视频在线播放| av超薄肉色丝袜交足视频| 国产男女内射视频| 国产精品99久久99久久久不卡| 亚洲精品久久成人aⅴ小说| 狠狠狠狠99中文字幕| e午夜精品久久久久久久| 久久国产亚洲av麻豆专区| 免费在线观看影片大全网站| 美女高潮喷水抽搐中文字幕| 如日韩欧美国产精品一区二区三区| 亚洲国产中文字幕在线视频| 午夜激情av网站| h视频一区二区三区| 亚洲黑人精品在线| 成人18禁在线播放| 又紧又爽又黄一区二区| 另类亚洲欧美激情| 一级片免费观看大全| www.熟女人妻精品国产| 亚洲中文字幕日韩| 又大又爽又粗| 大码成人一级视频| 午夜福利影视在线免费观看| 久久婷婷成人综合色麻豆| 亚洲视频免费观看视频| 大香蕉久久成人网| 黄色怎么调成土黄色| 亚洲熟女毛片儿| 99re6热这里在线精品视频| 亚洲五月婷婷丁香| 久久人人爽av亚洲精品天堂| 国产精品国产高清国产av | 亚洲伊人色综图| 视频区欧美日本亚洲| 久久精品国产99精品国产亚洲性色 | 91精品三级在线观看| 制服诱惑二区| 啦啦啦在线免费观看视频4| 自线自在国产av| 极品教师在线免费播放| 国产国语露脸激情在线看| 中文字幕高清在线视频| 色在线成人网| 国产伦人伦偷精品视频| 国产男女内射视频| 亚洲精品在线美女| 人妻一区二区av| 一区二区av电影网| 中文字幕高清在线视频| 巨乳人妻的诱惑在线观看| 狠狠狠狠99中文字幕| 成人三级做爰电影| 国产精品亚洲一级av第二区| 人人妻人人爽人人添夜夜欢视频| 久久精品成人免费网站| 中文字幕色久视频| 两性午夜刺激爽爽歪歪视频在线观看 | 亚洲欧美激情在线| 午夜福利一区二区在线看| 国产精品久久久久久人妻精品电影 | 超碰成人久久| 久久国产精品男人的天堂亚洲| av超薄肉色丝袜交足视频| 成人影院久久| 黄色 视频免费看| 18禁美女被吸乳视频| 中文字幕色久视频| 国产精品免费视频内射| 91麻豆精品激情在线观看国产 | 成人特级黄色片久久久久久久 | 色精品久久人妻99蜜桃| 久久人妻av系列| 丰满饥渴人妻一区二区三| 80岁老熟妇乱子伦牲交| 麻豆国产av国片精品| 精品国产国语对白av| 免费少妇av软件| 两性夫妻黄色片| 男男h啪啪无遮挡| 日韩 欧美 亚洲 中文字幕| 麻豆av在线久日| 久久久久久久久免费视频了| 在线观看人妻少妇| 国产成人影院久久av| 国产1区2区3区精品| 丁香欧美五月| 视频在线观看一区二区三区| 国产精品一区二区免费欧美| 日韩欧美国产一区二区入口| 欧美在线一区亚洲| 一级毛片女人18水好多| 久久久国产欧美日韩av| 久久精品91无色码中文字幕| 国产成人精品久久二区二区免费| 啦啦啦免费观看视频1| 亚洲五月婷婷丁香| 色播在线永久视频| 久久精品aⅴ一区二区三区四区| 欧美日韩一级在线毛片| 高清欧美精品videossex| 国产xxxxx性猛交| 一区在线观看完整版| 女性被躁到高潮视频| 高清视频免费观看一区二区| 首页视频小说图片口味搜索| 亚洲精品成人av观看孕妇| 国产三级黄色录像| 亚洲国产中文字幕在线视频| 精品国产亚洲在线| 精品国产一区二区三区久久久樱花| 亚洲avbb在线观看| 亚洲精品中文字幕在线视频| 一夜夜www| 亚洲精品久久午夜乱码| 国产亚洲精品第一综合不卡| 久久精品91无色码中文字幕| 国产av国产精品国产| 精品亚洲成国产av| 午夜福利在线观看吧| 亚洲欧美一区二区三区久久| 欧美黑人精品巨大| 国产极品粉嫩免费观看在线| 黄色成人免费大全| 一个人免费在线观看的高清视频| svipshipincom国产片| av线在线观看网站| 天天操日日干夜夜撸| 免费在线观看日本一区| avwww免费| 最黄视频免费看| 久热爱精品视频在线9| 五月开心婷婷网| 亚洲免费av在线视频| 亚洲三区欧美一区| 女人久久www免费人成看片| av网站在线播放免费| 亚洲精品国产区一区二| 亚洲国产精品一区二区三区在线| 窝窝影院91人妻| 国产精品香港三级国产av潘金莲| 99久久国产精品久久久| 国产精品1区2区在线观看. | 乱人伦中国视频| 欧美乱妇无乱码| 不卡av一区二区三区| 久久天堂一区二区三区四区| 亚洲伊人久久精品综合| 岛国在线观看网站| 国产精品二区激情视频| 在线av久久热| 精品国内亚洲2022精品成人 | 国产成人精品久久二区二区免费| 亚洲美女视频黄频| 非洲黑人性xxxx精品又粗又长| 99视频精品全部免费 在线 | 国产激情欧美一区二区| 美女午夜性视频免费| 久9热在线精品视频| 欧美日韩精品网址| 亚洲国产欧美人成| 精品无人区乱码1区二区| 亚洲专区国产一区二区| 国产亚洲av高清不卡| 国产免费av片在线观看野外av| 国产视频内射| 亚洲男人的天堂狠狠| 亚洲av成人不卡在线观看播放网| 一本久久中文字幕| 99久久成人亚洲精品观看| 精品久久久久久,| 亚洲欧美日韩高清专用| 精品福利观看| 国产精品女同一区二区软件 | 在线观看舔阴道视频| 97超视频在线观看视频| 校园春色视频在线观看| 91字幕亚洲| 久久性视频一级片| 欧美绝顶高潮抽搐喷水| 日本精品一区二区三区蜜桃| 99热这里只有精品一区 | 欧美日韩中文字幕国产精品一区二区三区| 亚洲精品乱码久久久v下载方式 | 午夜免费成人在线视频| 国产亚洲精品久久久com| 亚洲国产精品合色在线| 久久久久久大精品| 亚洲 欧美一区二区三区| 美女高潮喷水抽搐中文字幕| 熟女少妇亚洲综合色aaa.| 2021天堂中文幕一二区在线观| 三级毛片av免费| 人妻夜夜爽99麻豆av| 精品免费久久久久久久清纯| netflix在线观看网站| 男女床上黄色一级片免费看| 成人18禁在线播放| 美女午夜性视频免费| 久久精品国产99精品国产亚洲性色| 日本黄色视频三级网站网址| 免费人成视频x8x8入口观看| 国产亚洲精品av在线| 国产欧美日韩精品亚洲av| 久久人妻av系列| 午夜a级毛片| 久久久久国产一级毛片高清牌| 99国产极品粉嫩在线观看| 国产真实乱freesex| 亚洲人成网站在线播放欧美日韩| 欧美日韩乱码在线| 看黄色毛片网站| 久久精品综合一区二区三区| 真实男女啪啪啪动态图| 婷婷六月久久综合丁香| www国产在线视频色| 欧美一区二区精品小视频在线| 国产亚洲av嫩草精品影院| av福利片在线观看| 日韩av在线大香蕉| 日韩精品中文字幕看吧| 久久精品综合一区二区三区| 日本一本二区三区精品| 精品国产三级普通话版| 亚洲成a人片在线一区二区| 久久久久久人人人人人| 亚洲五月婷婷丁香| av天堂中文字幕网| 欧美激情在线99| 亚洲国产欧美网| 日韩三级视频一区二区三区| 亚洲欧洲精品一区二区精品久久久| 亚洲精品在线观看二区| 亚洲欧美日韩高清专用| 不卡一级毛片| 日本一二三区视频观看| 黄色成人免费大全| 久久亚洲真实| www日本在线高清视频| 免费大片18禁| netflix在线观看网站| 色综合站精品国产| 国产精品电影一区二区三区| 丰满人妻一区二区三区视频av | 18美女黄网站色大片免费观看| 国产精品国产高清国产av| 欧美激情在线99| 久久久久国产精品人妻aⅴ院| 精品国产乱码久久久久久男人| 91九色精品人成在线观看| 综合色av麻豆| 中文字幕av在线有码专区| 19禁男女啪啪无遮挡网站| 日日夜夜操网爽| 久久精品影院6| 国产伦精品一区二区三区四那| 国产亚洲欧美在线一区二区| 成人欧美大片| 变态另类丝袜制服| 国产精品野战在线观看| 国产一区二区激情短视频| 国产人伦9x9x在线观看| 一a级毛片在线观看| 国产v大片淫在线免费观看| 午夜免费成人在线视频| 免费在线观看成人毛片| 99国产极品粉嫩在线观看| 无人区码免费观看不卡| 日韩人妻高清精品专区| 国产成人aa在线观看| 12—13女人毛片做爰片一| cao死你这个sao货| 国产毛片a区久久久久| 亚洲av第一区精品v没综合| 亚洲国产精品合色在线| 成人午夜高清在线视频| 欧美不卡视频在线免费观看| 欧美黑人巨大hd| 一级黄色大片毛片| 高清毛片免费观看视频网站| 熟女电影av网| 亚洲五月婷婷丁香| 亚洲 欧美 日韩 在线 免费| 免费观看的影片在线观看| 三级国产精品欧美在线观看 | 免费av不卡在线播放| 欧美成人性av电影在线观看| 中文在线观看免费www的网站| 美女大奶头视频| 欧美日韩福利视频一区二区| 国产乱人伦免费视频| 露出奶头的视频| 啦啦啦观看免费观看视频高清| 午夜福利欧美成人| 欧美色欧美亚洲另类二区| 麻豆久久精品国产亚洲av| 夜夜爽天天搞| 脱女人内裤的视频| 丰满人妻一区二区三区视频av | 啪啪无遮挡十八禁网站| 99久久国产精品久久久| 国产一区二区三区视频了| 99在线视频只有这里精品首页| 亚洲专区中文字幕在线| aaaaa片日本免费| 亚洲 国产 在线| 美女高潮的动态| 男人舔女人的私密视频| 在线免费观看不下载黄p国产 | 97超视频在线观看视频| 久久久久久久久免费视频了| 亚洲熟妇中文字幕五十中出| 日日夜夜操网爽| 一个人免费在线观看的高清视频| 欧美高清成人免费视频www| 日韩欧美免费精品| 色老头精品视频在线观看| 亚洲黑人精品在线| 亚洲熟女毛片儿| 久久久国产成人免费| 久久欧美精品欧美久久欧美| 免费在线观看亚洲国产| 亚洲国产精品sss在线观看| 99久久综合精品五月天人人| 巨乳人妻的诱惑在线观看| 级片在线观看| 99精品欧美一区二区三区四区| 真人做人爱边吃奶动态| 久久中文字幕人妻熟女| 成人国产综合亚洲| 成年人黄色毛片网站| 免费在线观看影片大全网站| 非洲黑人性xxxx精品又粗又长| 少妇人妻一区二区三区视频| www.精华液| 亚洲18禁久久av| 中文字幕高清在线视频| а√天堂www在线а√下载| 在线观看免费视频日本深夜| 午夜福利视频1000在线观看| 国产爱豆传媒在线观看| 国产日本99.免费观看|